1. |
Welsby IJ, Newman MF, Phillips-Bute B, et al. Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery. Anesthesiology, 2005, 102(2): 308-314.
|
2. |
Kimmel SE, Sekeres M, Berlin JA, et al. Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass. Anesth Analg, 2002, 94(6): 1402-1408.
|
3. |
Raikar GV, Hisamochi K, Raikar BL, et al. Nitric oxide inhibition attenuates systemic hypotension produced by protamine. J Thorac Cardiovasc Surg, 1996, 111(6): 1240-1246.
|
4. |
Kalathottukaren MT, Abraham L, Kapopara PR, et al. Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA. Blood, 2017, 129(10): 1368-1379.
|
5. |
Sommers CD, Ye H, Liu J, et al. Heparin and homogeneous model heparin oligosaccharides form distinct complexes with protamine: Light scattering and zeta potential analysis. J Pharm Biomed Anal, 2017, 140: 113-121.
|
6. |
方强, 石应康, 张尔永, 等. 心内直视术中鱼精蛋白毒副反应的危险因素分析. 中国胸心血管外科临床杂志, 2003, 10(3): 177-180.
|
7. |
Gueugniaud PY, David JS, Chanzy E, et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med, 2008, 359(1): 21-30.
|
8. |
Fulton LV, Aitken J, Avery J, et al. Comparative resuscitative methods for venlafaxine toxicity in a swine model. Mil Med, 2016, 181(4): 383-388.
|
9. |
陈永福, 罗业春, 覃祖光. 体外循环术后不同途径输注鱼精蛋白对血流动力学的影响. 中国现代药物应用, 2015, 9(5): 103-104.
|
10. |
杨彦博, 任旭东, 张巧燕, 等. 不同途径中和肝素对先天性心脏病合并肺动脉高压术后肺循环的影响. 重庆医学, 2013, 42(34): 4152-4154.
|
11. |
张为民, 申伟林, 张帅, 等. 小量预注法预防鱼精蛋白毒性反应的临床观察. 中国社区医师, 2013, 15(20): 18-19.
|
12. |
陈青云, 华东, 郑和平. 氯化钙预防鱼精蛋白不良反应临床观察. 罕少疾病杂志, 2013, 20(3): 37-41.
|